NCT05313659View on ClinicalTrials.gov

Intramuscular Ketamine Effect on Postnasal Surgery Agitation

PHASE2CompletedINTERVENTIONAL
Enrollment

193

Participants

Timeline

Start Date

May 11, 2022

Primary Completion Date

October 20, 2022

Study Completion Date

October 20, 2022

Conditions
Agitation, Emergence
Interventions
DRUG

Ketamine Hydrochloride

intramuscular ketamine hydrochloride at dose of 0.7 mg/kg at the time of turning the inhalational agent off

Trial Locations (1)

11855

Jordanian Royal Medical Services, Amman

All Listed Sponsors
lead

Jordanian Royal Medical Services

OTHER